EDXC, VGHI & Extended Watchlist

ENDEXX Corp. EDXC

We noticed that this medical marijuana stock that we’ve talked about in the past is currently the subject of some promotional activity, based on the chatter we were observing over the weekend. The last time we mentioned EDXC was on April 9th. We saw a run in the following days; the stock was as low as .06 on the 16th, and reached a subsequent high of .105 the next day.
As for today, we are looking to take advantage of any price surge that may occur as a result of the pending promotions, locking in profits by selling into strength, and exiting before the excitement dies down. We expect a pullback to immediately follow any significant run, at which time we can re-assess the feasibility of re-entry.

This play is another prime example of a stock that we’ve already been tracking and are familiar with, being the focal point of promotional activity. As is often the case, we bring these plays to our audience well in advance. It is also the reason why we continually track all of the stocks that appear in our reports, even after the trail has gone cold, because you never know when one is going to heat up once again.

 

PHOENIX, April 29, 2013 /PRNewswire/ — Endexx Corporation (OTC Pink: EDXC) introduces M3 Hub (Medical Marijuana Management) and www.m3hub.com.

The M3 Hub Technology Platform is a new division of Endexx and is being prepared for “go to market” in 2013/2014. Over 18 States have received voter approval for the legalization and advancement of the Medical Marijuana Movement. Endexx initiated an intense due diligence and technology solutions research cycle at the beginning of 2013. We have established key industry relationships, made two acquisitions and have identified multiple joint venture candidates, technology and service alliances and most importantly the necessary technology solutions that will establish M3 Hub as one of the key companies in the sustainability and growth of the Medical Marijuana Industry. Please visit the new website for further information on the company.

Continue reading “EDXC, VGHI & Extended Watchlist”

ARNA, VGHI & Today’s Extended Watchlist

Arena Pharmaceuticals, Inc. ARNA

We have been covering ARNA for quite some time, since we learned of the possibility of an FDA approval. Yesterday that became a reality, with everyone and their brother discussing ARNA’s FDA approval, including the talking heads on CNBC. Around midday, the stock was briefly halted, before the announcement was made:

“On June 27, Arena Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved BELVIQ as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in obese or overweight adult patients. BELVIQ is the first prescription weight-loss treatment approved by the FDA in 13 Years.”

Shortly following, the stock was reopened for trading, and trade it did! 90.2 million shares, over 4 times the 3mo. average, traded hands. ARNA rose to a high of 13.50. We first alerted ARNA on May 11th, after which time the stock was trading as low as 5.44. That would represent a gain of 148% to yesterday’s high of 13.50.

We feel that once the initial clamor subsides, and the volitility calms a bit, we should see a bit of a pullback, as is to be expected with most astronomical gainers. That being said, the long-term for this stock looks very promising indeed, so while the excitement should begin to die down, our interest in following ARNA moving forward will not.

____

VHGI Holdings, Inc. VHGI

Monday, we stated: “On Friday the stock saw abnormally high volume coupled with the 52-week low, prompting us to put VHGI back on our watchlist in anticipation of an eventual bounce.”

It seems we came to this observation just in nick of time. The stock was as low as .055 following this alert. Since then it has seen a high of .095, equating to a gain of 73%. Those that have been with us for awhile know we are not one hit wonders in most cases when we cover a stock.

We will continue to monitor VHGI as it recovers off of its bottom, and in reality, we would not be shocked to see it return to previous support and higher. When we first covered this play, it ran from .20 to .75, and thus huge gains do not seem out of the realm of possibility for VHGI.

____

Extended Watchlist:

   EBIG, EEDG, AGDY, UNDR